Cardiology

Myoview^™ (technetium Tc-99m tetrofosmin)

A cardiac imaging agent, is useful in the diagnosis and localization of regions of reversible myocardial ischemia in the presence or absence of infarction under exercise and rest conditions.

Omnipaque^™ (iohexol)

The world's leading contrast agent for X-ray and has been used in over 200 million patients worldwide. Its indications include a broad range of intravascular diagnostic procedures such as coronary angiography, spinal cord imaging and body-cavity procedure

Optison^™ (Perflutren Protein-Type A Microspheres for Injection, USP)

An ultrasound contrast agent used for the diagnosis of cardiac wall motion abnormalities.

Visipaque^™ (iodixanol)

Visipaque is indicated for Contrast Enhanced Computer Tomography (CECT) imaging of the head and body.

Neurology

Omniscan^™ (gadodiamide)

Uses MRI to visualize lesions with abnormal vascularity which may result in the detection of a malignancy, such as neoplasms, abscesses, subacute infarcts and malignant and nonmalignant tumors.

Visipaque^™ (iodixanol)

Visipaque is indicated for Contrast Enhanced Computer Tomography (CECT) imaging of the head and body.

Oncology

Adreview ^™ (Iobenguane I 123 Injection)

AdreView is a diagnostic radio-pharmaceutical agent for gamma-scintigraphy. AdreView demonstrates high sensitivity and specificity in the detection of pheochromocytoma and neuroblastoma.

Omnipaque^™ (iohexol)

The world's leading contrast agent for X-ray and has been used in over 200 million patients worldwide. Its indications include a broad range of intravascular diagnostic procedures such as coronary angiography, spinal cord imaging and body-cavity procedure

Omniscan^™ (gadodiamide)

Uses MRI to visualize lesions with abnormal vascularity which may result in the detection of a malignancy, such as neoplasms, abscesses, subacute infarcts and malignant and nonmalignant tumors.

Visipaque^™ (iodixanol)

Visipaque is indicated for Contrast Enhanced Computer Tomography (CECT) imaging of the head and body.